These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9689191)

  • 1. Relationship between circulating estradiol levels, body mass index, and breakthrough bleeding in postmenopausal women receiving hormone replacement therapy.
    Büyük E; Gürler A; Erenus M
    Menopause; 1998; 5(1):24-7. PubMed ID: 9689191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial safety and bleeding pattern during a five-year treatment with long-cycle hormone therapy.
    Odmark IS; Bixo M; Englund D; Risberg B; Jonsson B; Olsson SE
    Menopause; 2005; 12(6):699-707. PubMed ID: 16278613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding patterns during continuous estradiol with different sequential progestogens therapy.
    Di Carlo C; Sammartino A; Di Spiezio Sardo A; Tommaselli GA; Guida M; Mandato VD; D'Elia A; Nappi C
    Menopause; 2005; 12(5):520-5. PubMed ID: 16145305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential combined transdermal and oral postmenopausal hormone replacement therapies: effects on bleeding patterns and endometrial histology.
    Sendag F; Terek MC; Karadadas N
    Arch Gynecol Obstet; 2001 Nov; 265(4):209-13. PubMed ID: 11789748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of initial gestagen treatment on bleeding patterns in postmenopausal women receiving continuous combined hormone replacement therapy.
    Büyük E; Durmuşoğlu F; Dökmeci C
    Menopause; 1999; 6(2):156-60. PubMed ID: 10374223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound determination of the effect of progestogens on the endometrium in postmenopausal women receiving hormone replacement therapy.
    Meuwissen JH; van Langen H; Navarro I
    Maturitas; 1994 Feb; 18(2):77-85. PubMed ID: 8177096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
    Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
    Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic hormone replacement therapy using quarterly progestin.
    Ettinger B; Selby J; Citron JT; Vangessel A; Ettinger VM; Hendrickson MR
    Obstet Gynecol; 1994 May; 83(5 Pt 1):693-700. PubMed ID: 8164927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapy.
    van de Weijer PH; Barentsen R; de Vries M; Kenemans P
    Obstet Gynecol; 1999 Apr; 93(4):551-7. PubMed ID: 10214832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
    Byrjalsen I; Thormann L; Meinecke B; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Apr; 79(4):523-8. PubMed ID: 1532445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
    Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.